Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2013 / Cilt: 21 - Sayı: 4

The role of pulmonary thromboendarterectomy in management of chronic thromboembolic pulmonary hypertension: a case report

Kronik tromboembolik pulmoner hipertansiyon tedavisinde pulmoner tromboendarterektominin yeri: Olgu sunumu

Pages
1129–1133
Publication Date
2022-09-02
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, we present a case of CTEPH patient who underwent a successful PEA and died following surgery.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary thromboendarterectomy (PEA) is a single treatment of choice in selected patients with chronic thromboembolic pulmonary hypertension (CTEPH).
📊
Key Findings & Data:Pulmonary thromboendarterectomy may be life- saving for patients with increased pulmonary vascular resistance (PVR) and proximal segment disease of the pulmonary arteries.
💡
Conclusion & Impact:In this article, we present a case of CTEPH patient who underwent a successful PEA and died following surgery.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary thromboendarterectomy (PEA) is a single treatment of choice in selected patients with chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary thromboendarterectomy may be life- saving for patients with increased pulmonary vascular resistance (PVR) and proximal segment disease of the pulmonary arteries. A 72-year-old male case had a 50-80% occlusion in pulmonary artery branches due to chronic thromboembolism. Echocardiography revealed a pulmonary artery pressure (PAP) of 110 mmHg, while right heart catheterization showed a mean PAP of 43 mmHg and PVR of 850 dyn/s/cm-5. The patient who was diagnosed with CTPEH underwent PEA. Pulmonary artery pressure was reduced to 40 mmHg at postoperative day 15. The patient died on postoperative day 22 due to a sudden cardiac arrest. Surgery is the most effective treatment approach for CTPEH cases. All risk factors should be carefully evaluated to reduce postoperative mortality. In this article, we present a case of CTEPH patient who underwent a successful PEA and died following surgery.

Özet

Pulmoner tromboendarterektomi (PEA), seçilmiş kronik tromboembolik pulmoner hipertansiyon (KTEPH) hastalarının tek tedavi seçeneğidir. Pulmoner trom- boendarterektomi, artmış pulmoner vasküler direnç (PVR) ve pulmoner arterlerde proksimal segment hastalığı olan hastalarda hayat kurtarıcı olabilir. Yetmişiki yaşında erkek olguda, kronik tromboemboliye bağlıpulmoner arter dallarında %50-80 oranında tıkanma var idi. Ekokardiyografide pulmoner arter basıncı (PAB)110 mmHg, sağ kalp kateterizasyonunda ortalama PAB 43 mmHg ve PVR 850 dyn/s/cm-5 idi. Kronik tromboembolik pulmoner hipertansiyon tanısı konulan hastayaPEA yapıldı. Pulmoner arter basıncı ameliyat sonrası15. günde 40 mmHg’ya indi. Hasta 22. günde ani gelişen kardiyak arrest nedeni ile kaybedildi. Kronik trombo- embolik pulmoner hipertansiyon olgularında en etkili tedavi yaklaşımı cerrahidir. Ameliyat sonrası mortalite- yi azaltmak için tüm risk faktörleri dikkatlice değerlen- dirilmelidir. Bu makalede, başarılı geçen PEA ameliyatısonrası kaybedilen bir KTEPH olgusu sunuldu.

🔖

Cite This Article

OKUTAN, O., AYTEN, Ö., URSAVAŞ, T. N., ÖZTUTGAN, T., KARTALOĞLU, Z., YILDIZELİ, B., DEMİRER, E. (2022). The role of pulmonary thromboendarterectomy in management of chronic thromboembolic pulmonary hypertension: a case report. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 21 - Sayı: 4, 1129–1133. https://ajindex.com/articles/424479

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Riedel M, Stanek V, Widimsky J, Prerovsky I. Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81:151-8
  2. Hollister LE, Cull VL. The syndrome of chronic thrombosis of the major pulmonary arteries. Am J Med 1956;21:312-20
  3. Mayer E, Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc 2006;3:589-93
  4. Doyle RL, McCrory D, Channick RN, Simonneau G, Conte J; American College of Chest Physicians. Surgical treatments/ interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:63S-71S
  5. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-8
  6. Yildizeli B, Isbir S. Pulmonary thromboendarterectomy. [Article in Turkish] Anadolu Kardiyol Derg 2010;10 Suppl 2:31-8
  7. Archibald CJ, Auger WR, Fedullo PF, Channick RN, Kerr KM, Jamieson SW, et al. Long-term outcome after Crit pulmonary thromboendarterectomy. Am J Respir Care Med 1999;160:523-8
  8. Cabrol C, Cabrol A, Acar J, Gandjbakhch I, Guiraudon G, Laughlin L, et al. Surgical correction of chronic postembolic obstructions of the pulmonary arteries. J Thorac Cardiovasc Surg 1978;76:620-8
  9. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993;106:116-26.